The Integrated Microscopy Facility (IMF) functions as a supervised, user-based Core providing state-of-the-art microscopy imaging capabilities to University of Chicago Medicine Comprehensive Cancer Center (UCCCC) members and other University investigators. Light microscopy is an essential technology for cancer investigators. Modern microscopy enables observation of ever-finer detail, now breaking the optical diffraction barrier to yield super-resolution detail, thus providing information at scales ranging from tens of millimeters to less than 10 nanometers. The IMF offers all major wide-field and confocal techniques in addition to super- resolution technologies (e.g., stimulated emission depletion (STED), localization, structured light), and works to advance these methodologies for application to cancer research. Specific IMF developments in the current funding period include significant upgrades to microscope technologies and data analysis tools. Notably, these include installation of GSD super-resolution, a Lightsheet.z1 system, a SP8 white-light-laser spectral confocal, additional high-end workstations and upgrade to full-feature Imaris software. IMF staff additionally provides equipment maintenance, user training, and expert advice. Budgets reflect strictly a cost-recovery operation, with all services provided ?at-cost?. As an integrated Core, IMF allows for efficient pooling of resources and management, while creating a large user base that aids in leveraging support from the University as well as other agencies and keeping costs low. Half of the IMF usage is associated with research conducted by UCCCC members. Specifically, UCCCC labs are major users of the IMF; for any given service that approaches capacity usage, every effort is made to ensure priority access for UCCCC investigators. Institutional support mechanisms significantly enhance UCCCC research efforts within the IMF. The Biological Science Division (BSD) invested $1,001,408 in the Core in 2016 alone to purchase equipment requested by UCCCC members. The Core supported the work of 99 UCCCC investigators in the current funding period (2013-2016), which included 647 individual users of IMF services.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014599-43
Application #
9489796
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-22
Budget End
2019-03-31
Support Year
43
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Luke, Jason J; Lemons, Jeffrey M; Karrison, Theodore G et al. (2018) Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol 36:1611-1618
Wang, Amy Y; Weiner, Howard; Green, Margaret et al. (2018) A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. J Hematol Oncol 11:4
Sample, Ashley; He, Yu-Ying (2018) Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed 34:13-24
Jeong, Choongwon; Witonsky, David B; Basnyat, Buddha et al. (2018) Detecting past and ongoing natural selection among ethnically Tibetan women at high altitude in Nepal. PLoS Genet 14:e1007650
Wang, Xin; Wu, Xingye; Zhang, Zhonglin et al. (2018) Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway. Sci Rep 8:17914
Brown, Hailey M; Biering, Scott B; Zhu, Allen et al. (2018) Demarcation of Viral Shelters Results in Destruction by Membranolytic GTPases: Antiviral Function of Autophagy Proteins and Interferon-Inducible GTPases. Bioessays 40:e1700231
Karrison, Theodore; Kocherginsky, Masha (2018) Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials? Clin Trials 15:178-188
An, Ningfei; Khan, Saira; Imgruet, Molly K et al. (2018) Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS. Blood 131:2682-2697
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74

Showing the most recent 10 out of 668 publications